Daktari Biotechnology - Innovation-Focused Volume 1, May 2024

Patrick Shompole, BVM PhD
Chris Kemp, PhD
He is a scientist and businessman based in
Washington State and Kenya. He holds a Bachelor of
Veterinary Medicine degree from the University of
Nairobi, Master of Science in Immuno-parasitology,
and PhD in Hemo-parasitology from Washington
State University. He also holds Specialty certificates
in Dementia-Alzheimer Disease, Mental Illness and
Developmental Disabilities in Home Healthcare in
the State of Washington, USA. Dr. Shompole worked
as a Senior Research Officer and Head of the
Immunology and Biotechnology Laboratory at the
Kenya Agricultural Research Institute (KARI), Kabete.
Concurrently, he works as the Kenya Resident
Scientist and Adjunct Professor for Washington
State University Animal Health Component under
the USAID Small-Ruminant Collaborative Research
Program. He has worked in the Department of
Veterinary Microbiology and Pathology at
Washington State University Pullman and University
of Idaho Department of Microbiology, Biochemistry
and Molecular Biology where he worked extensively
on various aspects of infectious cattle diseases
especially in host-pathogen interactions. He is part of
the 40 Scholars co-founding Diaspora University
Town.
DKTB board member is the Founder
and former President of Kempbio
now known as Kemp Proteins, a
protein expression and development
services company based in Frederick,
Maryland.
Kemp Proteins CRO provides services
for its customers on large-scale
biomanufacturing for diagnostic and
pre-GMP applications of proteins. He
has over 30 years’ experience with
commercial baculovirus protein
expression.
The Scientific Founders Significance to
Dakati Biotechnology
The scientific founders of Daktari Biotechnology have significantly impacted medicine and vaccine
development. Dr. Wilson O. Endege has earned five patents in cancer biomarkers and innovated protein
production technologies. Dr. Benson J. Edagwa invented LASER ART therapy for HIV and developed
synthesis strategies for combating infectious diseases. Dr. Frederick M. Boyce created the Bacmam
baculovirus technology, advancing protein expression in biotech. Dr. Chris Kemp has enhanced largescale
biomanufacturing with his expertise in baculovirus protein expression. Dr. Benard A. Ayanga's
work on tumor biology and genetic engineering has advanced understanding of cancer and kidney
diseases. Dr. Patrick Shompole has explored host-pathogen interactions, aiding infectious disease
management. Their collective work has been crucial in developing modern healthcare solutions.
By Joan Cheboswony M.P.H., M.Ed., P.G.D.E.